AIM Compliance

This site contains key corporate, financial and shareholder information for Bioventix plc. The information disclosed is for the purposes of AIM Rule 26.

Last updated 10 December 2020.

Company Information

Address7 Roman’s Business Park, East Street, Farnham, Surrey GU9 7SX
Company Number4923945
VAT NumberGB 822 6186 34
Country of Incorporation/Company OperationUnited Kingdom
Registered OfficeCargil Management Services Ltd
27-28 Eastcastle Street, London W1W 8DH
Key BusinessHealthcare, Diagnostics
Key ProductsSheep Monoclonal Antibodies
Constitutional Documents
Articles of Association
AIM Admission Document

Directors and Advisers

Directors:Ian James Nicholson, Non-Executive Chairman
Peter John Harrison, Chief Executive Officer
Bruce Edward Heath Hiscock, Chief Finance Officer
Nicholas John McCooke, Non-Executive Director
All of: Bioventix Plc, 7 Romans Business Park, East Street, Farnham, Surrey, GU9 7SX
Nominated Adviser & Broker:finnCap Limited
60 New Broad Street, London EC2M 1JJ
Reporting Accountant & Auditor:James Cowper LLP
3 Wesley Gate, Queen’s Road, Reading RG1 4AP
Registrars:Share Registrars Limited, The Courtyard, 17 West Street, Farnham GU9 7DR

Committees and Members

Remuneration Committee:Nick McCooke (Chair)
Ian Nicholson
Audit Committee:Ian Nicholson (Chair)
Nick McCooke
Nomination Committee:Nick McCooke (Chair)
Ian Nicholson

Share Information

Primary Trading Exchange:London Stock Exchange AIM
Other exchanges or trading platforms where shares traded:None
Share Identification Ticker:AIM:BVXP
Share Type and Value:Ordinary Shares £0.05 each
Number of Securities in Issue:5,209,333
Percentage of shares not in public hands:48%
Restrictions on transfer of shares:None

Significant Shareholdings

Sanford DeLand (Castlefield)20.0%
Canaccord (Hargreave Hale)8.6%
Peter Harrison8.0%
Gresham House (Livingbridge)4.8%
Schroder Investment Management2.9%
Hargreaves Lansdown Fund Managers2.3%
Danske Bank1.2%
Premier (Miton Group)1.1%

Corporate Governance

Bioventix plc is committed to maintaining high standards of corporate governance and has adopted the QCA Corporate Governance Code (“the Code”). The Board has reviewed the corporate governance framework that Bioventix plc operates and considers it to be effective and proportional to the size, risks, complexity and operations of Bioventix plc and reflective of the company’s culture and values. Details of how Bioventix plc complies with the Code can be found in the Chairman’s Corporate Governance Statement.


Terms of Reference for Bioventix plc Board Committees are as follows:

Audit Committee

Remuneration Committee

Nomination Committee


Bioventix plc is subject to the UK City Code on Takeovers and Mergers.

Download the at-a-glance Key Facts summary for Bioventix plc